New genetic risk factors for depression have been identified across all major global populations for the first time, allowing scientists to predict risk of depression regardless of ethnicity.
AlloVir lays off 95% of staffers after shuttering PhIII antiviral cell therapy trials
AlloVir is laying off 95% of its workers to “reduce costs and preserve capital” after discontinuing three Phase III trials of its antiviral cell therapy